Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly ALTU-238 vs Daily Nutropin AQ in Pediatric GHD
NCT00837863Phase 2Unknown
- Sponsor
- Altus Pharmaceuticals Inc.
- Start
- Mar 2009
- Primary completion
- Sep 2010
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of somatropin (ALTU-238) in growth hormone deficiency (GHD), sponsored by Altus Pharmaceuticals Inc.. Status: unknown.
02
Drugs
somatropin (ALTU-238)
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT00837863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00837863.